Soleus Capital Management’s Zymeworks ZYME Stock Holding History

Soleus Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$250K	Sell	10,000 -90,000	-90%	-$2.13M	0.01%	90
2025 Q4	$2.63M	Buy	+100,000	New	+$2.18M	0.1%	76
2021 Q1	–	Sell	-22,631	Closed	-$1.07M	–	83
2020 Q4	$1.07M	Sell	22,631 -66,602	-75%	-$3.09M	0.14%	51
2020 Q3	$4.16M	Sell	89,233 -331,603	-79%	-$11.4M	2.2%	17
2020 Q2	$15.2M	Buy	420,836 +359,308	+584%	+$13.2M	8.65%	1
2020 Q1	$2.18M	Buy	61,528 +38,828	+171%	+$1.59M	2.54%	15
2019 Q4	$1.03M	Buy	+22,700	New	+$825K	0.99%	28

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Soleus Capital Management's ZYME Position: Q1 2026 in Review

Soleus Capital Management reduced its Zymeworks (ZYME) stake by 90% in Q1 2026, selling an estimated $2.13M and leaving 10,000 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #90.

Soleus Capital Management first reported a position in ZYME in Q4 2019 and has held it in 7 quarters since. The position peaked at $15.2M in Q2 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Soleus Capital Management held 10,000 shares of Zymeworks worth $250K as of Q1 2026.
Soleus Capital Management sold 90,000 Zymeworks shares in Q1 2026, an estimated $2.13M.
Zymeworks made up 0.01% of Soleus Capital Management's portfolio in Q1 2026, its #90 holding.
Soleus Capital Management first reported a position in Zymeworks in Q4 2019 and has held it in 7 quarters since.
Soleus Capital Management's Zymeworks position peaked at $15.2M in Q2 2020.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.